Comparator product issues for biowaiver implementation: the case of Fluconazole. Braz. J. Pharm. Sci. [Internet]. 2022 Nov. 23 [cited 2024 Jun. 26];58. Available from: https://journals.usp.br/bjps/article/view/204705